About the role
Mercor is partnering with a biotech and pharma research team on expert human-evaluation work — creating and critiquing rubrics that analyze commercial drugs and drug-development programs. We're seeking a biotech investment analyst (specialist-fund background) for a paid pilot, with the potential to continue as the work scales. Create and critique rubrics that analyze commercial drugs and drug-development programs.
Experience
US-based biotech / healthcare investment analyst with a specialist-fund background. Familiarity with biotech/pharma development programs. Able to assess a drug asset and the company behind it end-to-end. 5+ years evaluating biotech/pharma companies or assets. Engagement Details . Duration: Approximately 10–20 hours over a 1–2 week pilot. Remote — US-based. Why Participate . Help improve expert AI evaluation of drugs and drug-development programs.
Selection process
Apply on the official platform. The listing does not describe further selection steps.
Eligibility
Not specified by the source